Epigral (EPIGRAL)

STALWART

FairStock Score: 26/100 — RISKY

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹1,192.45
Market Cap₹3,847.34 Cr
P/E Ratio11.39
ROCE24.88%
ROE24.13%
Dividend Yield0.67%
Profit Growth-62.19%
Debt/Equity0.26
Sales Growth-7.46%
Promoter Holding68.83%
52-Week Range₹807 — ₹2,114
SectorChemicals & Petrochemicals
Book Value₹321.22

Epigral trades with a P/E ratio of 11.39, ROCE of 24.88%, ROE of 24.13%, profit growth of -62.19%, debt-to-equity of 0.26. The FairStock Score of 26/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer